SCHEMBL8445704

SCHEMBL8445704

[CH2][C@@H](C)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8445834 1.00
SCHEMBL39214 1.00
SCHEMBL28382963 0.96
Water SCHEMBL28145231 0.96
Alcohol SCHEMBL4828524 0.73
SCHEMBL270511 0.72
SCHEMBL4148800 0.72
Isobutanol SCHEMBL969 0.70
SCHEMBL1033934 0.70
Isobutanol SCHEMBL175952 0.70 TSHR (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102532768-B Method for preparing low-temperature soluble polymer thin film in neutral aqueous solution UNIV JILIN 2013-10-16 CN claimed
CN-102532768-A Method for preparing low-temperature soluble polymer thin film in neutral aqueous solution UNIV JILIN 2012-07-04 CN claimed
CN-1310629-A Combined administration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions WARNER LAMBERT CO (US) 2001-08-29 CN claimed
CN-1254334-A Novel terephthalamide derivatives DONGWHA PHARMACEUTICAL IND CO (KR) 2000-05-24 CN claimed
CN-1233237-A Heteroaryl succinamides and their use as metalloproteinase inhibitors AGOURON PHARMA (US) 1999-10-27 CN claimed
US-5922871-A VIRICIDE DONGWHA PHARMACEUTICAL IND. CO., LTD. (KR) 1999-07-13 US claimed
WO-1998054140-A1 NOVEL TEREPHTHALAMIDE DERIVATIVES DONGWHA PHARMACEUTICAL IND. CO., LTD. (KR) 1998-12-03 WO claimed
EP-3298003-B1 BENZOIMIDAZOLE DERIVATIVES AS PAD4 INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2023-04-19 EP disclosed
EP-3911698-A1 STABILIZER COMPOSITION FOR SEALANTS AND ADHESIVES BASF SE (DE) 2021-11-24 EP disclosed
CN-107849015-B Benzimidazole derivatives as PAD4 inhibitors 葛兰素知识产权发展有限公司 2021-03-19 CN disclosed
US-10815218-B2 Benzoimidazole derivatives as PAD4 inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-10-27 US disclosed
WO-2020148211-A1 STABILIZER COMPOSITION FOR SEALANTS AND ADHESIVES BASF SE (DE) 2020-07-23 WO disclosed
US-20200095227-A1 BENZOIMIDAZOLE DERIVATIVES AS PAD4 INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-03-26 US disclosed
CN-102471258-A 3-phenoxymethylpyrrolidine compounds THERAVANCE INC 2012-05-23 CN disclosed
CN-101384603-A Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases BAYER HEALTHCARE AG (DE) 2009-03-11 CN disclosed
CN-101151265-A Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent LG LIFE SCIENCES LTD (KR) 2008-03-26 CN disclosed
CN-1254334-A Novel terephthalamide derivatives DONGWHA PHARMACEUTICAL IND CO (KR) 2000-05-24 CN disclosed
CN-1233237-A Heteroaryl succinamides and their use as metalloproteinase inhibitors AGOURON PHARMA (US) 1999-10-27 CN disclosed
US-5922871-A VIRICIDE DONGWHA PHARMACEUTICAL IND. CO., LTD. (KR) 1999-07-13 US disclosed
WO-1998054140-A1 NOVEL TEREPHTHALAMIDE DERIVATIVES DONGWHA PHARMACEUTICAL IND. CO., LTD. (KR) 1998-12-03 WO disclosed